DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146 | -19.3% | 16,348 | +1.3% | 0.00% | – |
| Q2 2023 | $181 | -20.3% | 16,132 | -18.0% | 0.00% | – |
| Q1 2023 | $227 | -0.4% | 19,678 | 0.0% | 0.00% | – |
| Q4 2022 | $228 | -99.9% | 19,678 | +0.0% | 0.00% | – |
| Q3 2022 | $250,000 | +85.2% | 19,677 | +0.4% | 0.00% | – |
| Q2 2022 | $135,000 | -28.9% | 19,599 | -0.4% | 0.00% | – |
| Q1 2022 | $190,000 | -18.8% | 19,669 | +0.1% | 0.00% | – |
| Q4 2021 | $234,000 | -26.9% | 19,644 | -0.4% | 0.00% | – |
| Q3 2021 | $320,000 | -41.1% | 19,718 | -23.7% | 0.00% | -100.0% |
| Q2 2021 | $543,000 | +235.2% | 25,830 | +148.4% | 0.00% | – |
| Q1 2021 | $162,000 | -25.7% | 10,400 | 0.0% | 0.00% | – |
| Q4 2020 | $218,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |